Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: An Italian survey study on 220 cardiology departments

Journal of Cardiovascular Medicine

Volumn 13, Issue 11, 2012, Pages 675-683

  Inama, Giuseppe ^a   Pedrinazzi, Claudio ^a   Landolina, Maurizio ^b   Oliva, Fabrizio ^c   Senni, Michele ^d   Proclemer, Alessandro ^e   Berisso, Massimo Zoni ^f   Pirelli, Salvatore ^g  

^a MAGGIORE HOSPITAL   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Cardiovascular Department   (Italy)

^d OSPEDALI RIUNITI   (Italy)

^e AOUS Maria della Misericordia ^*  (Italy)

^f Padre Antero Micone Hospital   (Italy)

^g Cardiovascular Unit   (Italy)

Author keywords

heart failure; implantable cardioverter defibrillator; sudden death

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAM; HEALTH CARE QUALITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL DEPARTMENT; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; ITALY; PRACTICE GUIDELINE; QRS COMPLEX; RISK REDUCTION; SUDDEN DEATH; TREATMENT INDICATION;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOLOGY SERVICE, HOSPITAL; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; ITALY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84869880718     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32834bd918     Document Type: Article

References (37)

1. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001; 104:2158-2163. (Pubitemid 33043293)
2. Hoyert DL, Heron MP, Murphy SL, Kung HC. Deaths: final data for 2003. Natl Vital Stat Rep 2006; 54:1-120.
3. Myerburg RJ, Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease: a textbook of cardiovascular medicine. Philadelphia: WB Saunders; 2001. pp. 890-931.
4. Cobbe SM, Dalziel K, Ford I, Marsden AK. Survival of 1476 patients initially resuscitated from out-of-hospital cardiac arrest. BMJ 1996; 312:1633- 1637. (Pubitemid 26229450)
5. Liberthson RR, Nagel EL, Hirschman JC, Nussenfeld SR. Prehospital ventricular defibrillation: prognosis and follow-up course. N Engl J Med 291:317-321.
6. Schaffer WA, Cobb LA. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation. N Engl J Med 1975; 293:259-262.
7. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhmic-drug therapy with iplantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
8. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101:1297-1302. (Pubitemid 30158618)
9. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102:748-754. (Pubitemid 30648765)
10. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Antiarrhythmics vs. Implantable Defibrillator study; Cardiac Arrest Study Hamburg; Canadian Implantable Defibrillator Study. Eur Heart J 2000; 21:2071-2078.
11. Dickstein K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Reply. Eur Heart J 2008; 29:2388-2442.
12. Di Lenarda A, Scherillo M, Maggioni AP, et al., for the TEMISTOCLE Investigators. Current presentation and management of heart failure in cardiology and internal medicine hospital units: a tale of two worlds. The TEMISTOCLE study. Am Heart J 2003; 146:e12.
13. Maggioni AP, Sinagra G, Opasich C, et al. Treatment of chronic heart failure with beta-adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 2003; 89:299-305. (Pubitemid 36241543)
14. Tavazzi L, Tognoni G, Franzosi MG, et al., on behalf of the GISSI-HF Investigators. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur J Heart Fail 2004;6:635-641. (Pubitemid 39070519)
15. Senni M, De Maria R, Gregori D, et al., on behalf of IN-CHF Investigators. Temporal trends in survival and hospitalizations among out-patients with chronic heart failure, in 1995 and 1999. Report from the Italian Network on Congestive Heart Failure (IN-CHF). J Card Fail 2005; 11:270- 278. (Pubitemid 40616896)
16. Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006; 113:1424-1433. (Pubitemid 43739439)
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbility in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383. (Pubitemid 17055592)
18. EZipes DP, Camm AJ, Borggrefe M, et al. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48:e247-e346.
19. Lunati M, Bongiorni MG, Boriani G, et al. AIAC Guidelines on cardiac pacing, resynchronization therapy and ICD implantation. Giornale Italiano di Aritmologia e Cardiostimolazione (GIAC) 2005; 8:1-58.
20. Moss AJ, Hall WJ, Cannom DS, et al. Multicenter automatic defibrillator implantation trial investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-1940. (Pubitemid 26428217)
21. Buxton AE, Lee KL, Fisher JD, et al., for the Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341:1882-1890.
22. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883. (Pubitemid 34984635)
23. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004; 351:2481-2488. (Pubitemid 39603155)
24. Steinbeck G, Andresen D, Seidl KH, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med 2009; 361:1427-1436.
25. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237. (Pubitemid 40110811)
26. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350:2140-2150.
27. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361:1329- 1338.
28. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008; 117:e350- e408.
29. Dickstein K, Vardas PE, Auricchio A, et al. 2010 focused update of ESC guidelines on device therapy in heart failure. An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac resynchronization therapy. Europace 2010; 12:1526-1536.
30. Metra M, Nodari S, Parrinello G, et al. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Am Heart J 2003; 145:292-299. (Pubitemid 36207951)
31. Grimm W, Christ M, Bach J, Muller HH, Maish B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003; 108:2883-2891. (Pubitemid 37517816)
32. Zoni Berisso M. Clinical significance of cardiac arrhythmias in patients with ischemic heart disease and idiopathic dilative cardiomyopathy. In: Santini M, editor. Trattato Italiano di Elettrofisiologia ed Elettrostimolazione Cardiaca. Torino: Centro Scientifico Editore; 2010: 220-226.
33. Ansalone G, Giannantoni P, Santini M. Prognostic stratification of arrhythmic risk in idiopathic dilative cardiomyopathy. G ital Cardiol 1998; 28:1288-1302. (Pubitemid 28545656)
34. Salerno-Uriarte JA, De Ferrari GM, Klersy C, et al., for the ALPHA Study Group Investigators. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: result of the ALPHA Study. J Am Coll Cardiol 2007; 50:1896- 1904. (Pubitemid 350019444)
35. Daubert JP, Zareba W, Hall WJ, et al., MADIT II Study Investigators. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol 2006; 47:98-107. (Pubitemid 43005171)
36. Buxton AE, Lee KL, Hafley GE, et al., for the MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial. Circulation 2002; 106:2466- 2472. (Pubitemid 35278803)
37. Wilber DJ, Olshansky B, Moran JF, Scanlon PJ. Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function. Circulation 1990; 82:350-358. (Pubitemid 20257813)